 NEW YORK, Jan. 09, 2023 GLOBE NEWSWIRE BeyondSpring Inc. the Company or BeyondSpring Nasdaq: BYSI, a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that on December 29, 2022, the Company received a written notification the Notification Letter on Compliance from Nasdaq that the Company has regained compliance with the ... The post BeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Ru... 